Lovastatin Tablet
Product Images NDC 68071-3127

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 68071-3127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 3127 9

Lovastatin 20 mg tablets packaging label by NuCare Pharmaceuticals, Inc. The label indicates a 90-count bottle with each round white/off-white tablet containing 20 mg Lovastatin USP, engraved with 'CTI 142'. It includes instructions to take the tablets every 12 hours and warnings to keep out of reach of children. Storage conditions specify controlled temperature of 68-77°F. The label shows NDC 68071-3127-9 and product number P0555090.*

FDA Label Image

Structural Formula (Lov00 0004 01)

Chemical structure of Lovastatin depicting its molecular arrangement with rings, hydroxyl, keto, and methyl functional groups as part of the active ingredient structure.*

FDA Label Image

Table I (Lov00 0004 02)

A data table titled 'The Effect of Other Drugs on Lovastatin Exposure When Both Were Co-administered' showing drug interactions. It lists drugs coadministered with lovastatin, number of subjects, dosing of coadministered drugs or grapefruit juice, dosing of lovastatin, and AUC ratios (with/without coadministered drug) for lovastatin and total lovastatin acid.*

FDA Label Image

Figure 1 (Lov00 0004 03)

A line graph titled 'Acute Major Coronary Events (Primary Endpoint)' showing the proportion of participants without event on the y-axis versus years of follow-up on the x-axis. Two lines compare Lovastatin and Placebo, indicating a lower event rate and 37% risk reduction with Lovastatin over approximately 6 years.*

FDA Label Image

Table Vii (Lov00 0005 04)

A data table titled 'Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis' listing interacting agents such as strong CYP3A4 inhibitors, HIV protease inhibitors, gemfibrozil, cyclosporine, and others, alongside prescribing recommendations for lovastatin including contraindications, dose limits, and avoidance of grapefruit juice.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.